======= NFKBIB ======= == Gene Information == * **Official Symbol**: NFKBIB * **Official Name**: NFKB inhibitor beta * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4793|4793]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15653|Q15653]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NFKBIB&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NFKBIB|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604495|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene belongs to the NF-kappa-B inhibitor family, which inhibit NF-kappa-B by complexing with, and trapping it in the cytoplasm. Phosphorylation of serine residues on these proteins by kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B, which translocates to the nucleus to function as a transcription factor. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jul 2011]. * **UniProt Summary**: Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. However, the unphosphorylated form resynthesized after cell stimulation is able to bind NF-kappa-B allowing its transport to the nucleus and protecting it to further NFKBIA- dependent inactivation. Association with inhibitor kappa B- interacting NKIRAS1 and NKIRAS2 prevent its phosphorylation rendering it more resistant to degradation, explaining its slower degradation. |Ank| |Ank 2| |cellular response to lipopolysaccharide| |cellular response to molecule of bacterial origin| |cellular response to biotic stimulus| |transcription coactivator activity| |response to lipopolysaccharide| |response to molecule of bacterial origin| |cellular response to lipid| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |response to bacterium| |response to lipid| |cellular response to oxygen-containing compound| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |response to other organism| |organic cyclic compound biosynthetic process| |response to external biotic stimulus| |response to biotic stimulus| |response to oxygen-containing compound| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.93| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|1.85| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|2.04| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.597| Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|2/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15602 * **Expression level (log2 read counts)**: 5.37 {{:chemogenomics:nalm6 dist.png?nolink |}}